Phase Ii Study Of Clinical Activity And Proteomic Profiling Of The Vegfr2 Inhibitor Vandetanib In Women With Relapsed Or Refractory Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
CANCER RESEARCH(2009)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined